Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
204 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Cancer Care Associates
Fresno, California, United States
- Front Range Cancer Specialists
Fort Collins, Colorado, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Mcfarland Clinic, Pc
Ames, Iowa, United States
- Cedar Rapids Oncology Associates
Cedar Rapids, Iowa, United States
- Mercy Regional Cancer Center at Mercy Medical Center
Cedar Rapids, Iowa, United States
- Medical Oncology and Hematology Associates - West Des Moines
Clive, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at Mercy Cancer Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Mercy Capitol Hospital
Des Moines, Iowa, United States
- Mccreery Cancer Center at Ottumwa Regional
Ottumwa, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Lawrence Memorial Hospital
Lawrence, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 31 Oct 2010
- Completion
- 19 Feb 2014
- Last update posted
- 8 May 2018
- Registered enrollment
- 54
- Registry id
- NCT00621686
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.